Urinary cytology and nuclear matrix protein 22 in the detection of bladder cancer recurrence other than transitional cell carcinoma

BJU International

Volumn 101, Issue 5, 2008, Pages 561-565

  Hutterer, Georg C ^a,b   Karakiewicz, Pierre I ^a   Zippe, Craig ^c   Lüdecke, Gerson ^d   Boman, Hans ^e   Sanchez Carbayo, Marta ^f,g   Casella, Roberto ^h   Mian, Christine ^e,i   Friedrich, Martin G ^j   Eissa, Sanaa ^k   Akaza, Hideyuki ^l   Serretta, Vincenzo ^m   Hedelin, Hans ^e   Rupesh, Raina ^c   Miyanaga, Naoto ^l   Sagalowsky, Arthur I ⁿ   Perrotte, Paul ^a   Lotan, Yair ⁿ   Marberger, Michael J ⁱ   Shariat, Shahrokh F ⁿ  

^a CENTRE HOSPITALIER DE L UNIVERSITÉ DE MONTRÉAL   (Canada)

^b MEDICAL UNIVERSITY OF GRAZ   (Austria)

^c LERNER RESEARCH INSTITUTE   (United States)

^d JUSTUS LIEBIG UNIVERSITY   (Germany)

^e Karnsjukhuset Skovde ^*  (Italy)

^f HOSPITAL UNIVERSITARIO DE SALAMANCA   (Spain)

^g MEMORIAL SLOAN KETTERING CANCER CENTER   (United States)

^h UNIVERSITY OF BASEL   (Switzerland)

ⁱ UNIVERSITY OF VIENNA   (Austria)

^j UNIVERSITY MEDICAL CENTER HAMBURG EPPENDORF   (Germany)

^k AIN SHAMS UNIVERSITY   (Egypt)

^l UNIVERSITY OF TSUKUBA   (Japan)

^m UNIVERSITY OF PALERMO   (Italy)

ⁿ UNIVERSITY OF TEXAS SOUTHWESTERN MEDICAL CENTER   (United States)

more..

Author keywords

Bladder cancer; Disease recurrence; NMP22; Prediction; Squamous cell carcinoma; Transitional cell carcinoma

Indexed keywords

NUCLEAR MATRIX PROTEIN 22;

ADULT; ARTICLE; BLADDER CANCER; CANCER DIAGNOSIS; CANCER RECURRENCE; CANCER RISK; CLINICAL TRIAL; DIAGNOSTIC ACCURACY; DIAGNOSTIC VALUE; FEMALE; HUMAN; INTERMETHOD COMPARISON; MAJOR CLINICAL STUDY; MALE; MULTICENTER STUDY; PREDICTIVE VALIDITY; PRIORITY JOURNAL; PROTEIN URINE LEVEL; TRANSITIONAL CELL CARCINOMA; URINE CYTOLOGY;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; CARCINOMA, SQUAMOUS CELL; CHILD; COHORT STUDIES; FEMALE; HUMANS; MALE; MIDDLE AGED; NEOPLASM RECURRENCE, LOCAL; NUCLEAR PROTEINS; PREDICTIVE VALUE OF TESTS; PROGNOSIS; RETROSPECTIVE STUDIES; RISK FACTORS; SENSITIVITY AND SPECIFICITY; TUMOR MARKERS, BIOLOGICAL; URINARY BLADDER NEOPLASMS;

EID: 38849101720     PISSN: 14644096     EISSN: 1464410X     Source Type: Journal    
DOI: 10.1111/j.1464-410X.2007.07352.x     Document Type: Article

References (18)

1. Heney NM, Ahmed S, Flanagan MJ et al. Superficial bladder cancer. progression and recurrence. J Urol 1983 130 : 1083 6
2. Ghoneim MA, el-Mekresh MM, El-Baz MA, El-Attar IA, Ashamallah A. Radical cystectomy for carcinoma of the bladder. Critical evaluation of the results in 1026 cases. J Urol 1997 158 : 393 9
3. Dahm P, Gschwend JE. Malignant non-urothelial neoplasms of the urinary bladder: a review. Eur Urol 2003 44 : 672 81
4. Koss LG, Deitch D, Ramanathan R, Sherman AB. Diagnostic value of cytology of voided urine. Acta Cytol 1985 29 : 810 6
5. Soloway MS, Briggman JV, Carpinito GA et al. Use of a new tumor marker, urinary NMP22, in the detection of occult or rapidly recurring transitional cell carcinoma of the urinary tract following surgical treatment. J Urol 1996 156 : 363 7
6. Keesee SK, Briggman JV, Thill G, Wu YJ. Utilization of nuclear matrix proteins for cancer diagnosis. Crit Rev Eukaryot Gene Expr 1996 6 : 189 214
7. Ponsky LE, Sharma S, Pandrangi L et al. Screening and monitoring for bladder cancer: refining the use of NMP22. J Urol 2001 166 : 75 8
8. Raj GV, Bochner BH, Vickers A et al. Association between urinary cytology and pathology for nontransitional cell malignancies of the urinary tract. J Urol 2006 175 : 2038 41
9. Eissa S, Swellam M, Sadek M, Mourad MS, Ahmady OE, Khalifa A. Comparative evaluation of the nuclear matrix protein, fibronectin, urinary bladder cancer antigen and voided urine cytology in the detection of bladder tumors. J Urol 2002 168 : 465 9
10. Efron B, Tibshirani RJ. The bootstrap estimate of standard error. In An Introduction to the Bootstrap. New York : Chapman & Hall, 1998 : 45
11. Broecker BH, Klein FA, Hackler RH. Cancer of the bladder in spinal cord injury patients. J Urol 1981 125 : 196 7
12. Locke JR, Hill DE, Walzer Y. Incidence of squamous cell carcinoma in patients with long-term catheter drainage. J Urol 1985 133 : 1034 5
13. Bejany DE, Lockhart JL, Rhamy RK. Malignant vesical tumors following spinal cord injury. J Urol 1987 138 : 1390 2
14. Bickel A, Culkin DJ, Wheeler JS. Bladder cancer in spinal cord injury patients. J Urol 1991 146 : 1240 2
15. Wiener HG, Vooijs GP, van't Hof-Grootenboer B. Accuracy of urinary cytology in the diagnosis of primary and recurrent bladder cancer. Acta Cytol 1993 37 : 163 9
16. Melzak J. The incidence of bladder cancer in paraplegia. Paraplegia 1966 4 : 85 96
17. Stonehill WH, Goldman HB, Dmochowski RR. The use of urine cytology for diagnosing bladder cancer in spinal cord injured patients. J Urol 1997 157 : 2112 4
18. Shariat SF, Zippe C, Ludecke G et al. Nomograms including nuclear matrix protein 22 for prediction of disease recurrence and progression in patients with Ta, T1 or CIS transitional cell carcinoma of the bladder. J Urol 2005 173 : 1518 25